• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由……引起的原发性和继发性菌血症:流行病学、菌株敏感性及生物膜形成

Primary and Secondary Bacteremia Caused by spp.: Epidemiology, Strains Susceptibility and Biofilm Formation.

作者信息

Kwiecińska-Piróg Joanna, Skowron Krzysztof, Gospodarek-Komkowska Eugenia

机构信息

Department of Microbiology, Nicolaus Copernicus University in Toruń, L. Rydygier Collegium Medicum in Bydgoszcz , Poland.

出版信息

Pol J Microbiol. 2018;67(4):471-478. doi: 10.21307/pjm-2018-055.

DOI:10.21307/pjm-2018-055
PMID:30550233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7256738/
Abstract

Proteus spp. is an etiological factor of urinary tract and bloodstream infections. The aim of this study was the retrospective analysis of susceptibility of Proteus spp. strains isolated from bloodstream infections (BSIs) as well as similarity evaluation of the strains isolated from different clinical samples. Proteus spp. strains were isolated in 2009-2017 from hospital patients. Identification was based on the colony's morphology and biochemical or MALDI-TOF MS analyzes. The antibiotic susceptibility test was done using the diffusion method. Biofilm formation was evaluated with microplate method using TTC. Bacteremia caused by Proteus spp. was found in 97 patients, mainly secondary to urinary tract infection. Most of the strains were susceptible to piperacillin with tazobactam (95.9%) and amikacin (86.7%). Elderly patients have a higher risk of mortality after BSIs caused by Proteus spp. A detailed analysis was made for randomly chosen 26 strains isolated from 11 patients with Proteus mirabilis bacteremia. Using PFGE, we found that 10 (90.9%) isolates, collected from different clinical specimens of the same patient, were genetically identical. spp. is an etiological factor of urinary tract and bloodstream infections. The aim of this study was the retrospective analysis of susceptibility of spp. strains isolated from bloodstream infections (BSIs) as well as similarity evaluation of the strains isolated from different clinical samples. spp. strains were isolated in 2009–2017 from hospital patients. Identification was based on the colony’s morphology and biochemical or MALDI-TOF MS analyzes. The antibiotic susceptibility test was done using the diffusion method. Biofilm formation was evaluated with microplate method using TTC. Bacteremia caused by spp. was found in 97 patients, mainly secondary to urinary tract infection. Most of the strains were susceptible to piperacillin with tazobactam (95.9%) and amikacin (86.7%). Elderly patients have a higher risk of mortality after BSIs caused by spp. A detailed analysis was made for randomly chosen 26 strains isolated from 11 patients with bacteremia. Using PFGE, we found that 10 (90.9%) isolates, collected from different clinical specimens of the same patient, were genetically identical.

摘要

变形杆菌属是泌尿道和血流感染的一个病因。本研究的目的是对从血流感染(BSIs)中分离出的变形杆菌属菌株的药敏性进行回顾性分析,以及对从不同临床样本中分离出的菌株进行相似性评估。变形杆菌属菌株于2009年至2017年从医院患者中分离得到。鉴定基于菌落形态以及生化或基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)分析。采用扩散法进行抗生素药敏试验。使用氯化三苯基四氮唑(TTC)通过微孔板法评估生物膜形成。97例患者中发现了由变形杆菌属引起的菌血症,主要继发于尿路感染。大多数菌株对哌拉西林他唑巴坦(95.9%)和阿米卡星(86.7%)敏感。老年患者在由变形杆菌属引起的血流感染后有更高的死亡风险。对从11例奇异变形杆菌菌血症患者中随机选取的26株菌株进行了详细分析。使用脉冲场凝胶电泳(PFGE),我们发现从同一患者的不同临床标本中收集的10株(90.9%)分离株在基因上是相同的。变形杆菌属是泌尿道和血流感染的一个病因。本研究的目的是对从血流感染(BSIs)中分离出的变形杆菌属菌株的药敏性进行回顾性分析,以及对从不同临床样本中分离出的菌株进行相似性评估。变形杆菌属菌株于2009年至2017年从医院患者中分离得到。鉴定基于菌落形态以及生化或基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)分析。采用扩散法进行抗生素药敏试验。使用氯化三苯基四氮唑(TTC)通过微孔板法评估生物膜形成。97例患者中发现了由变形杆菌属引起的菌血症,主要继发于尿路感染。大多数菌株对哌拉西林他唑巴坦(95.9%)和阿米卡星(86.7%)敏感。老年患者在由变形杆菌属引起的血流感染后有更高的死亡风险。对从11例奇异变形杆菌菌血症患者中随机选取的26株菌株进行了详细分析。使用脉冲场凝胶电泳(PFGE),我们发现从同一患者的不同临床标本中收集的10株(90.9%)分离株在基因上是相同的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d18/7256738/d96e908a7d15/pjm-67-4-471-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d18/7256738/b627b8f89aae/pjm-67-4-471-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d18/7256738/d96e908a7d15/pjm-67-4-471-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d18/7256738/b627b8f89aae/pjm-67-4-471-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d18/7256738/d96e908a7d15/pjm-67-4-471-g002.jpg

相似文献

1
Primary and Secondary Bacteremia Caused by spp.: Epidemiology, Strains Susceptibility and Biofilm Formation.由……引起的原发性和继发性菌血症:流行病学、菌株敏感性及生物膜形成
Pol J Microbiol. 2018;67(4):471-478. doi: 10.21307/pjm-2018-055.
2
Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase-producing Proteus mirabilis.碳青霉烯类药物和哌拉西林/他唑巴坦用于治疗由产超广谱β-内酰胺酶的奇异变形杆菌引起的菌血症。
Diagn Microbiol Infect Dis. 2014 Nov;80(3):222-6. doi: 10.1016/j.diagmicrobio.2014.07.006. Epub 2014 Jul 26.
3
Antibiotic resistance pattern among biofilm producing and non producing Proteus strains isolated from hospitalized patients; matter of hospital hygiene and antimicrobial stewardship.从住院患者中分离出的产生物膜和不产生物膜的变形杆菌菌株的抗生素耐药模式;医院卫生与抗菌药物管理问题
Pak J Biol Sci. 2013 Nov 15;16(22):1496-502. doi: 10.3923/pjbs.2013.1496.1502.
4
Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes.奇异变形杆菌尿路感染和菌血症:危险因素、临床表现和结局。
J Microbiol Immunol Infect. 2012 Jun;45(3):228-36. doi: 10.1016/j.jmii.2011.11.007. Epub 2012 May 7.
5
Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland.从波兰尿路感染中分离出的细菌菌株的抗生素敏感性
J Antimicrob Chemother. 2001 Jun;47(6):773-80. doi: 10.1093/jac/47.6.773.
6
Molecular epidemiology and antimicrobial susceptibility of AmpC- and/or extended-spectrum (ESBL) ß-lactamaseproducing Proteus spp. clinical isolates in Zenica-Doboj Canton, Bosnia and Herzegovina.波斯尼亚和黑塞哥维那泽尼察-多博伊州产AmpC和/或超广谱(ESBL)β-内酰胺酶变形杆菌临床分离株的分子流行病学及抗菌药物敏感性
Med Glas (Zenica). 2016 Aug 1;13(2):103-12. doi: 10.17392/853-16.
7
Bloodstream infections caused by multi-drug resistant Proteus mirabilis: Epidemiology, risk factors and impact of multi-drug resistance.多药耐药奇异变形杆菌引起的血流感染:流行病学、危险因素和多药耐药性的影响。
Infect Dis (Lond). 2016;48(6):428-31. doi: 10.3109/23744235.2015.1129551. Epub 2016 Jan 14.
8
Catalase Activity is Critical for Proteus mirabilis Biofilm Development, Extracellular Polymeric Substance Composition, and Dissemination during Catheter-Associated Urinary Tract Infection.过氧化氢酶活性对于奇异变形杆菌生物膜的形成、胞外聚合物质的组成以及在与导管相关的尿路感染期间的传播至关重要。
Infect Immun. 2021 Sep 16;89(10):e0017721. doi: 10.1128/IAI.00177-21. Epub 2021 Jul 19.
9
Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients.阿根廷关于哌拉西林-他唑巴坦对从住院患者中分离出的特定细菌菌株的体外比较活性的多中心合作研究。
Diagn Microbiol Infect Dis. 2003 Nov;47(3):527-37. doi: 10.1016/s0732-8893(03)00131-7.
10
Antimicrobial activities against biofilm formed by Proteus mirabilis isolates from wound and urinary tract infections.对从伤口和尿路感染中分离出的奇异变形杆菌形成的生物膜的抗菌活性。
Indian J Med Microbiol. 2012 Jan-Mar;30(1):76-80. doi: 10.4103/0255-0857.93044.

引用本文的文献

1
Proteus mirabilis in ICU Patients: Prevalence, Risk Factors, and Future Expectations of Bloodstream Infections.重症监护病房患者中的奇异变形杆菌:血流感染的患病率、危险因素及未来展望
Cureus. 2025 Aug 27;17(8):e91083. doi: 10.7759/cureus.91083. eCollection 2025 Aug.
2
Possible Association of Carbapenemase Production with Susceptibility Pattern and Resistance Genes Among Carbapenemase Producing Enterobacterales from Blood Isolates or Bacteremic Patients.产碳青霉烯酶肠杆菌科细菌血流分离株或菌血症患者中碳青霉烯酶产生与药敏模式及耐药基因的可能关联
Infect Drug Resist. 2025 May 16;18:2569-2579. doi: 10.2147/IDR.S519561. eCollection 2025.
3

本文引用的文献

1
Biofilm is a Major Virulence Determinant in Bacterial Colonization of Chronic Skin Ulcers Independently from the Multidrug Resistant Phenotype.生物膜是慢性皮肤溃疡细菌定植的主要毒力决定因素,与多重耐药表型无关。
Int J Mol Sci. 2017 May 17;18(5):1077. doi: 10.3390/ijms18051077.
2
The impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea.产超广谱β-内酰胺酶对韩国奇异变形杆菌菌血症患者28天死亡率的影响。
BMC Infect Dis. 2017 May 3;17(1):327. doi: 10.1186/s12879-017-2431-8.
3
Complete Genome Sequence of the First KPC-Type Carbapenemase-Positive Proteus mirabilis Strain from a Bloodstream Infection.
Patterns, Outcomes and Economic Burden of Primary vs. Secondary Bloodstream Infections: A Single Center, Cross-Sectional Study.
原发性与继发性血流感染的模式、结局及经济负担:一项单中心横断面研究
Pathogens. 2024 Aug 9;13(8):677. doi: 10.3390/pathogens13080677.
4
Population-based study of group bloodstream infections.基于人群的血流感染群组研究。
J Assoc Med Microbiol Infect Dis Can. 2023 Sep 18;8(2):134-140. doi: 10.3138/jammi-2022-0038. eCollection 2023 Sep.
5
Comparative Study of Biofilm Formation and Antimicrobial Susceptibility in Gram-Negative Bacilli Isolated from Prosthetic Joint Infections.革兰氏阴性杆菌在人工关节感染中生物膜形成与抗菌敏感性的比较研究。
Microbiol Spectr. 2022 Aug 31;10(4):e0085122. doi: 10.1128/spectrum.00851-22. Epub 2022 Jul 25.
6
Infective Endocarditis with a Left Ventricular Pseudoaneurysm Caused by : A Case Report.感染性心内膜炎合并左心室假性动脉瘤一例报告
J Cardiol Cases. 2021 Jul 23;25(2):79-82. doi: 10.1016/j.jccase.2021.06.013. eCollection 2022 Feb.
7
Sepsis-A Retrospective Cohort Study of Bloodstream Infections.脓毒症——血流感染的回顾性队列研究
Antibiotics (Basel). 2020 Nov 28;9(12):851. doi: 10.3390/antibiotics9120851.
8
Infective endocarditis by species: a systematic review.按物种分类的感染性心内膜炎:一项系统综述。
Germs. 2020 Sep 1;10(3):229-239. doi: 10.18683/germs.2020.1209. eCollection 2020 Sep.
首例血流感染的产KPC型碳青霉烯酶奇异变形杆菌菌株的全基因组序列
Genome Announc. 2016 Jun 23;4(3):e00607-16. doi: 10.1128/genomeA.00607-16.
4
Significance and Roles of Proteus spp. Bacteria in Natural Environments.变形杆菌属细菌在自然环境中的意义与作用
Microb Ecol. 2016 Nov;72(4):741-758. doi: 10.1007/s00248-015-0720-6. Epub 2016 Jan 9.
5
Population-based epidemiology and microbiology of community-onset bloodstream infections.社区获得性血流感染的基于人群的流行病学和微生物学
Clin Microbiol Rev. 2014 Oct;27(4):647-64. doi: 10.1128/CMR.00002-14.
6
Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program.奇异变形杆菌的抗菌药敏性:来自台湾抗菌药物耐药性监测计划(TSAR)的全国性纵向研究。
BMC Infect Dis. 2014 Sep 5;14:486. doi: 10.1186/1471-2334-14-486.
7
Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.生物膜相关感染:弥合临床管理与对抗生素顽固性的基本方面之间的差距。
Microbiol Mol Biol Rev. 2014 Sep;78(3):510-43. doi: 10.1128/MMBR.00013-14.
8
The assessment of Proteus mirabilis susceptibility to ceftazidime and ciprofloxacin and the impact of these antibiotics at subinhibitory concentrations on Proteus mirabilis biofilms.奇异变形杆菌对头孢他啶和环丙沙星敏感性的评估以及这些抗生素在亚抑菌浓度下对奇异变形杆菌生物膜的影响。
Biomed Res Int. 2013;2013:930876. doi: 10.1155/2013/930876. Epub 2013 Sep 12.
9
Effects of ceftazidime and ciprofloxacin on biofilm formation in Proteus mirabilis rods.头孢他啶和环丙沙星对变形杆菌棒状生物膜形成的影响。
J Antibiot (Tokyo). 2013 Oct;66(10):593-7. doi: 10.1038/ja.2013.59. Epub 2013 Jun 26.
10
Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis.融合神话与形态学:奇异变形杆菌的多面生活方式。
Nat Rev Microbiol. 2012 Nov;10(11):743-54. doi: 10.1038/nrmicro2890. Epub 2012 Oct 8.